Description of a clinical case of synchronous cancer in the native and graft kidneys
https://doi.org/10.17650/1726-9776-2017-13-4-122-125
Abstract
Kidney transplantation is the most frequently performed organ transplant procedure in the world. The occurrence of malignant tumors is one of the well-known late complications of organ transplantation, which is induced by immunosuppressive therapy. In the vast majority of patients, kidney cancer occurs in the native organs; however, in a small percentage of cases, malignancies are found in the graft organ. The article describes a rare clinical case of a patient with synchronous cancer in the native and graft kidneys.
About the Authors
A. V. Khaylenko
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
24 Kashirskoe Shosse, Moscow 115478; 1 Ostrovityanova St., Moscow 117997
V. A. Chernyaev
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
K. M. Figurin
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
V. B. Matveev
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
References
1. http://www.transplant-observatory.org/data-reports-2014/ [Accessed 17 February 17].
2. Hart A., Smith J.M., Skeans M.A. et al. Kidney. Am J Transplant 2016;16(2):11–46. DOI: 10.1111/ajt.13666. PMID: 26755262.
3. Penn I. Cancer in renal transplant recipients. Adv Ren Replace Ther 2000;7(2):147–56. PMID: 10782732.
4. Moloney F.J., Comber H., O’Lorcain P. et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006;154(3):498–504. DOI: 10.1111/j.1365–2133.2005.07021.x. PMID: 16445782.
5. Kearney L., Hogan D., Conlon P. et al. High-risk cutaneous malignancies and immunosuppression: challenges for thereconstructive surgeon in the renal transplant population. J Plast Reconstr Aesthet Surg 2017;70(7):922–30. DOI: 10.1016/j.bjps.2017.03.005. PMID: 28457679.
6. Ribal M.J., Rodriguez F., Musquera M. et al. Nephron-sparing surgery for renal tumor: a choice of treatment in an allograft kidney. Transplant Proc 2006;38(5):1359–62. DOI: 10.1016/j.transproceed.2006.03.033. PMID: 16797303.
7. Boix R., Sanz C., Mora M. et al. Primary renal cell carcinoma in a transplanted kidney: genetic evidence of recipient origin. Transplantation 2009;87(7):1057–61. DOI: 10.1097/TP.0b013e31819d1e5f. PMID: 19352128.
8. Rotman S., Druaz C., Venetz J.P. et al. De novo concurrent papillary renal cell carcinoma and angiomyolipoma in a kidney allograft: evidence of donor origin. Hum Pathol 2006; 37 (4):481–7. DOI: 10.1016/j.humpath.2005.11.024. PMID: 16564925
Review
For citations:
Khaylenko A.V., Chernyaev V.A., Figurin K.M., Matveev V.B. Description of a clinical case of synchronous cancer in the native and graft kidneys. Cancer Urology. 2017;13(4):122-125. (In Russ.) https://doi.org/10.17650/1726-9776-2017-13-4-122-125
Views:
945
Email this article 